Furthermore, patient-specific EC derived from iPSC have demonstrated a protective effect against pulmonary hypertension in familial pulmonary arterial hypertension with bone morphogenetic protein receptor type 2 (BMPR2) mutation13. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.